Posts

Cue Health racks up FDA’s first de novo nod for an at-h...

Cue Health has received the FDA’s first approval for regular use of a COVID-19 a...

Commercial Excellence Summit Brings Together Leading Mi...

This week is set to be a pivotal one in the life sciences industry. Leading mind...

Bon Secours Mercy Health And Anthem BCBS Lock Horns Ove...

Bon Secours Mercy Health is locking horns with Anthem Blue Cross and Blue Shield...

EHA 2023: Kura Oncology’s menin inhibitor ziftomenib sh...

Kura faces competition in the menin inhibitor market as the therapy is being dev...

Snap Spanish elections throw health reimbursement refor...

Two broad health reform initiatives are affected by the election.

US FDA approves Neobiosis’ IND for post-Covid syndrome ...

ViXome showed potent immunomodulatory and pro-reparative effects in pre-clinical...

FDA accepts AstraZeneca’s NDA for breast cancer combina...

The NDA submission was based on the findings of the CAPItello-291 Phase III trial.

Beacon Therapeutics enters gene therapy arena with $120...

Syncona launches its third gene therapy company to stake a claim in the ophthalm...

FDA gives Ferring go-ahead for Adstiladrin gene therapy...

Following a December approval, the FDA has now given Ferring Pharmaceuticals cle...

USPTO issues notice of allowance for Windtree’s SERCA2A...

The activators might represent both an outpatient, oral therapy for chronic hear...

US FDA approves Ironwood Pharmaceuticals’ LINZESS

The FDA approval was based on the findings obtained from a double-blind multi-ce...

Idorsia introduces Quviviq in Switzerland for chronic i...

The recommended dose of Quviviq is one 50mg tablet to be taken orally each night.

Novo Nordisk to invest $2.3bn to expand Danish manufact...

The new investment will be used to expand the company’s existing active pharmace...

Ro pauses advertising of weight loss drug Wegovy amid s...

Telehealth company Ro has paused advertising of the obesity drug Wegovy as the d...

Obesity impairs brain responses to nutrients, even afte...

“There’s a biological process ongoing that really explains why people are strugg...

STAT+: Pharmalittle: U.S. Chamber sues over Medicare pr...

The FDA is seeking new suppliers to ease shortages of methotrexate, one of the m...